Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

I doubt that Magniant can generate substantial sales. The entire sales that Ivivi had were an order from Allergan that subsequently they had to buy back because of the failed 510k. If I remember correctly they generated more sales from the big bulky device they sold and rented to a few elderly care homes. Unfortunately, wound care is a very complicated space that requires clinical data and the competitors in the space have large studies that demonstrate the economic value of their products.

The problem with this technology is that it has very little clinical data to demonstrate value to payers. I was invested back then and remember when they didn't get the 510k because they did not provide clinical data to support it. The studies that have been done using SofPulse are very small studies that really do not demonstrate value over standard of care. That is why they targeted breast augmentation surgeries because they do not have reimbursement and do not have large well controlled studies demonstrating the economic and clinical value of SofPulse over what is currently used. Essentially, SofPulse is marketed as an improvement over existing care but has no actual proof to show it.

The entire healthcare model is changing because it is too costly and outcomes do not match those costs. IMO, ENDV has good tech but a management team that is not even remotely competent to realize the true value of the tech.